trending Market Intelligence /marketintelligence/en/news-insights/trending/JLQY6H1cUyk8TugU943Irw2 content esgSubNav
In This List

Regulus Therapeutics appoints director

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Regulus Therapeutics appoints director

Regulus Therapeutics Inc. said Pascale Witz was elected to the board at the company's June 1 annual stockholders meeting.

Most recently, she served as executive vice president, diabetes and cardiovascular, for Sanofi.